IBM reported a 3% year-over-year decline in revenue and slower growth in strategic imperatives, which may raise concerns about its ability to return to growth. While management maintained full-year guidance and highlighted expected improvements in the second half with new product launches like the IBM Z14 mainframe, the market may react negatively in the short term due to the ongoing revenue declines and uncertainties.

[-1]